Yatrik M Shah Selected Research

Aryl Hydrocarbon Receptor Nuclear Translocator

2/2016	Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion.
10/2012	The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression.
6/2011	Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice.
6/2008	Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yatrik M Shah Research Topics

Disease

46	Hypoxia (Hypoxemia) 05/2022 - 06/2008
29	Neoplasms (Cancer) 11/2022 - 08/2005
17	Inflammation (Inflammations) 01/2022 - 02/2008
14	Colitis 01/2020 - 02/2007
10	Carcinogenesis 11/2017 - 06/2007
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2012
7	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2012
7	Iron Overload 01/2022 - 06/2013
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 02/2007
7	Insulin Resistance 05/2018 - 11/2007
6	Obesity 01/2022 - 10/2011
6	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2004
5	Iron Deficiencies 01/2022 - 02/2009
4	Adenocarcinoma 11/2022 - 04/2004
4	Anemia 01/2022 - 12/2013
4	Fibrosis (Cirrhosis) 10/2021 - 08/2011
4	Fatty Liver 01/2018 - 08/2011
4	Necrosis 09/2014 - 11/2007
3	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 01/2019
3	Adenoma (Adenomas) 01/2022 - 01/2018
3	Ulcerative Colitis 11/2018 - 02/2008
3	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 12/2010
3	Thalassemia 01/2016 - 03/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2014 - 01/2012
3	Body Weight (Weight, Body) 02/2014 - 02/2007
3	Hemorrhage 04/2011 - 02/2007
3	Diarrhea 10/2010 - 02/2007
3	Endometrial Neoplasms (Endometrial Cancer) 08/2005 - 04/2004
2	Lung Injury 05/2022 - 12/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2021
2	Hemochromatosis (Bronze Diabetes) 01/2022 - 01/2016
2	Weight Loss (Weight Reduction) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2013
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 07/2012
2	Liver Diseases (Liver Disease) 10/2021 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2018
2	Colitis-Associated Neoplasms 04/2019 - 11/2017
2	Infections 01/2019 - 12/2018
2	Pancreatitis 01/2018 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 12/2017 - 02/2012
2	Hemolysis 09/2015 - 12/2013
2	Liver Neoplasms (Liver Cancer) 02/2014 - 04/2008
2	Atherosclerosis 01/2012 - 11/2007

Drug/Important Bio-Agent (IBA)

24	IronIBA 01/2022 - 02/2009
23	Transcription Factors (Transcription Factor)IBA 05/2022 - 02/2007
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
13	Oxygen (Dioxygen)IBA 05/2022 - 08/2011
9	CytokinesIBA 01/2020 - 02/2007
7	Dextran SulfateIBA 01/2020 - 02/2008
6	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 04/2008
6	Messenger RNA (mRNA)IBA 12/2017 - 11/2006
6	pirinixic acidIBA 04/2016 - 06/2007
5	LipidsIBA 11/2022 - 08/2011
5	HepcidinsIBA 01/2021 - 03/2012
5	Tamoxifen FDA LinkGeneric 11/2020 - 04/2004
5	Insulin (Novolin)FDA Link 01/2018 - 11/2007
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2016 - 11/2007
4	NF-kappa B (NF-kB)IBA 05/2022 - 04/2007
4	Estrogen ReceptorsIBA 01/2022 - 04/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2012
4	ChromatinIBA 01/2021 - 08/2011
4	RNA (Ribonucleic Acid)IBA 04/2019 - 01/2017
4	LigandsIBA 01/2019 - 11/2006
4	LuciferasesIBA 01/2018 - 10/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 11/2007
4	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 02/2016 - 06/2008
4	Von Hippel-Lindau Tumor Suppressor ProteinIBA 01/2013 - 06/2008
3	Estrogens (Estrogen)FDA Link 01/2022 - 03/2005
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 04/2009
3	CateninsIBA 11/2020 - 05/2014
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 02/2016
3	Dextrans (Dextran)FDA Link 01/2017 - 09/2014
3	Bile Acids and Salts (Bile Acids)IBA 09/2014 - 07/2013
3	Triglycerides (Triacylglycerol)IBA 01/2013 - 06/2007
3	Rifaximin (L 105)FDA Link 06/2012 - 07/2007
3	PPAR alphaIBA 03/2010 - 06/2007
3	Estrogen Receptor alphaIBA 11/2006 - 08/2005
3	Estradiol (Delestrogen)FDA LinkGeneric 11/2006 - 04/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2017
2	3-hydroxypropionaldehydeIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2018
2	CalciumIBA 01/2021 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 04/2019 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 06/2012
2	EnzymesIBA 01/2019 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2016
2	Arginine (L-Arginine)FDA Link 01/2018 - 05/2014
2	Peptides (Polypeptides)IBA 01/2017 - 01/2016
2	MetalsIBA 01/2016 - 07/2015
2	Dietary IronIBA 01/2016 - 06/2013
2	GlobinsIBA 09/2015 - 12/2013
2	Fibric Acids (Fibrates)IBA 09/2014 - 04/2008
2	CholesterolIBA 04/2014 - 11/2007
2	member 2 solute carrier family 11- (proton-coupled divalent metal ion transporters)IBA 12/2013 - 05/2012
2	AdiponectinIBA 02/2013 - 10/2011
2	LDL Receptors (LDL Receptor)IBA 01/2012 - 11/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2004
2	Gastrectomy 01/2022 - 01/2022
2	Chemoprevention 02/2012 - 08/2005